Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3-(oxalyl-amino)-naphthalene-2-carboxylic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
**Description:** 3-(Oxalyl-Amino)-Naphthalene–2-Carboxylic Acid is a synthetic small molecule with the formula C13H9NO5. It is primarily used as an experimental or discovery agent in research settings and has not been approved for clinical use. The compound features an oxalyl group and a carboxylic acid moiety attached to a naphthalenic core, making it structurally unique among benzenoid compounds. Notably, it has been studied as an inhibitor of protein tyrosine phosphatase 1B (PTP1B), based on crystallographic data showing its binding to this enzyme[3]. PTP1B is implicated in the regulation of insulin signaling and metabolic pathways, suggesting potential utility for this compound in metabolic disease research; however, no clinical development or therapeutic indication has been established[1][5][7].
- Other names
- 3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid3-(oxaloamino)naphthalene-2-carboxylic acidN-(3-Carboxy-2-naphthyl)oxamidic acid3-[carboxycarbonyl]amino]naphthalene–2–carboxylic acid3-(carboxyformamido)naphthalene–2–carboxylic acid
02
Targets
PTPN1 (Protein tyrosine phosphatase 1B)
Beyond the preview
Go deeper on 3-(oxalyl-amino)-naphthalene-2-carboxylic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3-(oxalyl-amino)-naphthalene-2-carboxylic acid.